Morningside Ventures
Asia, Hong Kong Island, Hong Kong, Central'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
Description
Morningside Ventures is an investment firm.
Investor Profile
Morningside Ventures has backed more than 16 startups, with 0 new investments in the last 12 months alone. The firm has led 5 rounds, about 31% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series A rounds (top funding stages).
- Majority of deals are located in United States, China, United Kingdom.
- Strong thematic focus on Health Care, Biotechnology, Medical Device.
Stage Focus
- Series B (31%)
- Series C (25%)
- Series A (19%)
- Post Ipo Equity (6%)
- Private Equity (6%)
- Seed (6%)
- Series D (6%)
Country Focus
- United States (50%)
- China (19%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
- United Kingdom (19%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Singapore (6%)
'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
- The Netherlands (6%)
Industry Focus
- Health Care
- Biotechnology
- Medical Device
- Artificial Intelligence (Ai)
- Therapeutics
- Medical
- Health Diagnostics
- Life Science
- Pharmaceutical
- Clinical Trials
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
